This site is intended for healthcare professionals only
LoginRegister
Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel ReviewZydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol...
Himachal to develop medical device park independentlyMedical device manufacturers need to resubmit MSC and NCC as CDSCO launches Automated Process
AstraZeneca Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancerAstraZeneca Gets CDSCO Panel Nod To study Tezepelumab
Wockhardt seeks DCGI nod for ZaynichUS tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialNovartis plans to invest USD 23 billion over next 5 years in US based infrastructure
CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten StudyPomalyst monopoly case: Bristol Myers wins dismissal of lawsuit
Pharmacy Practice RegulationsD.Pharm To Remain Minimum Qualification To Become Pharmacist in Bihar: Patna HC
Morepen Labs plans to employ over 1000 professionalsMorepen Labs plans to employ over 1000 professionals
Raid at quack clinic in Telangana, drugs including Amoxycillin seizedRaid at quack clinic in Telangana, drugs including Amoxycillin seized
Zydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug IbrutinibZydus Lifesciences bags USFDA nod for Duchenne muscular dystrophy drug Jaythari
JnJ Nipocalimab gets USFDA Fast Track designation for Sjogrens diseaseJohnson & Johnson gets CDSCO Panel for additional indication of Amivantamab Liquid Concentrate for...
Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial MandatedSubmit Phase III CT data with Pk and Pd data: CDSCO Panel Tells Intas Pharmaceuticals on Human von...
X